Actionable news
All posts from Actionable news

Valeant Pharmaceuticals International (VRX) Earnings Report: Q3 2015 Conference Call Transcript

The following Valeant Pharmaceuticals International (VRX - Get Report) conference call took place on October 19, 2015, 08:00 AM ET. This is a transcript of that earnings call:

Company Participants

  • Laurie Little; Valeant Pharmaceuticals International; Head - IR
  • J. Michael Pearson; Valeant Pharmaceuticals International; Chairman and CEO
  • Rob Rosiello; Valeant Pharmaceuticals International; CFO
  • Ari Kellen; Valeant Pharmaceuticals International; Company Group Chairman

Other Participants

  • Shibani Malhotra; Nomura Securities; Analyst
  • Gregg Gilbert; Deutsche Bank; Analyst
  • Tim Chang; BTIG; Analyst
  • Louise Chen; Guggenheim; Analyst
  • Alex Arfaei; BMO Capital Markets; Analyst
  • Marc Goodman; UBS; Analyst
  • Irina Rivkind Koffler; Mizuho Securities; Analyst
  • David Amsellem; Piper Jaffray; Analyst
  • Lennox Gibbs; TD Securities; Analyst
  • Gary Nachman; Goldman Sachs; Analyst
  • David Risinger; Morgan Stanley; Analyst
  • Annabel Samimy; Stifel; Analyst
  • Chris Schott; JPMorgan; Analyst
  • Andrew Finkelstein; Susquehanna; Analyst
  • Douglas Tsao; Barclays Capital; Analyst
  • Sumant Kulkarni; Bank of Bank of America-Merrill Lynch; Analyst
  • Umer Raffat; Evercore ISI; Analyst
  • Douglas Miehm; RBC Capital Markets; Analyst
  • Gregg Gilbert; Deutsche Bank; Analyst
  • Alan Ridgeway; Scotiabank; Analyst
  • Jason Gerberry; Leerink Ppartners; Analyst

MANAGEMENT DISCUSSION SECTION Operator: Good morning. My name is Shawn and I will be your conference operator today. At this time, I would like to welcome everyone to the Valeant third-quarter 2015 earnings conference call. All lines have been placed on mute to prevent any background...">More